In Silico Modeling of Viral Envelope Fusion Kinetics and Transition States

The entry of enveloped viruses into host cells requires the fusion of the viral lipid envelope with a host cell membrane. This process is mediated by specialized viral fusion glycoproteins that undergo large-scale conformational rearrangements to drive the two membranes together. In veterinary virology, understanding the kinetics and transition states of viral envelope fusion is critical for predicting host range, designing antiviral interventions, and assessing zoonotic spillover risk. Computational modeling approaches now allow researchers to probe these biophysical events at atomic resolution, revealing the thermodynamic landscapes and structural intermediates that govern membrane fusion.

Conformational Transitions of Fusion Glycoproteins

Viral fusion glycoproteins are classified into three major structural classes. Class I fusion proteins, such as influenza hemagglutinin, exist in a metastable prefusion conformation and are triggered by low pH or receptor binding to undergo irreversible refolding. Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms, as demonstrated by Pabis et al. [1]. The first mechanism involves insertion of the fusion peptide into the target membrane, while the second involves a fold-back of the protein core that brings both membranes into close apposition. Class II fusion proteins, found in flaviviruses, exhibit sequential conformational rearrangements during membrane fusion, as elucidated by Chao et al. [2] using single-particle cryo-electron microscopy and kinetic assays. These rearrangements involve a transition from a dimeric prefusion state to a trimeric postfusion state, with intermediate states that expose the fusion loop.

In in silico studies, computational molecular dynamics simulations are used to model these conformational transitions. The free energy landscapes of fusion glycoprotein folding can be computed using enhanced sampling techniques such as umbrella sampling and metadynamics. Zhang and Dudko [3] applied statistical mechanics principles to model viral entry as a diffusive process over a free energy barrier, treating the fusion protein as a molecular machine that lowers the kinetic barrier to membrane merger. Their framework provides a quantitative description of the rate-limiting steps and the distribution of transition states.

Free Energy Barrier Modeling

The fusion of two lipid bilayers is thermodynamically unfavorable without catalytic intervention. Viral fusion proteins catalyze this process by lowering the activation free energy barrier. In silico models compute this barrier using continuum elasticity theory or atomistic simulations. The free energy of the stalk-pore transition pathway can be calculated as a function of membrane properties such as curvature, lipid composition, and sterol concentration. Zawada et al. [4] demonstrated that influenza viral membrane fusion is sensitive to sterol concentration but surprisingly robust to sterol chemical identity in a vesicle fusion assay. This finding implies that the free energy barrier is modulated by membrane order but not by specific sterol headgroup chemistry. These results inform computational models by constraining the parameters for lipid bilayer properties in simulations.

Transition state theory applied to protein-mediated fusion defines the transition state ensemble as the set of configurations with equal probability of proceeding to fusion or reverting to the prefusion state. Kipp et al. [5] showed that the transition states of native and drug-resistant HIV-1 protease are the same, using kinetic isotope effects. Although their study focused on a protease, the methodological principle of identifying transition states via free energy calculations is transferable to fusion protein systems. In a fusion context, the transition state corresponds to the point at which the outer leaflets of the two membranes have merged (the stalk), and the system must decide whether to expand into a hemifusion diaphragm or to revert.

Intermediate States in Membrane Fusion

Fusion proceeds through a series of well-defined intermediate states: (1) approach and docking, (2) stalk formation, (3) hemifusion, and (4) pore opening and expansion. Each intermediate is characterized by distinct lipid rearrangements and protein conformations. Computational models at coarse-grained and atomistic resolutions have captured these intermediates for several viral systems. The fusion loop of class II proteins, for example, inserts into the target membrane and anchors the protein during the intermediate states. Chao et al. [2] mapped sequential conformational rearrangements in flavivirus fusion, revealing an extended intermediate that bridges the viral and host membranes. Synthetic fusion peptides of tick-borne encephalitis virus studied by Pan et al. [6] provided a model system to probe the structure and membrane interactions of the fusion loop. Using NMR and circular dichroism, those authors demonstrated that the fusion peptide adopts a beta-strand conformation upon membrane binding, and that this conformation is critical for membrane destabilization.

In silico tools allow visualization of these fusion loops in a molecular viewer. Highlighting fusion loop regions in the viewer enables the comparison of electrostatic and hydrophobic properties across viral species. For veterinary pathogens such as avian influenza virus or porcine respiratory coronavirus, the fusion loop (or fusion peptide) sequence can be mapped onto a three-dimensional model generated by homology modeling. The Structural Bioinformatics of Viral Envelope Proteins and Entry Mechanisms article provides an overview of these visualization techniques.

Membrane Insertion and Lipid Interactions

The insertion of fusion peptides or fusion loops into the target membrane lowers the activation barrier by increasing local curvature and promoting lipid mixing. The depth of insertion, oligomerization state, and secondary structure all influence fusogenic activity. Qiang and Weliky [7] showed that the HIV fusion peptide adopts a beta-strand conformation that correlates with membrane cholesterol content and positions the peptide close to lipid headgroups. Their cross-linking experiments demonstrated that a trimeric oligomer is required for full fusion activity. This structural requirement can be incorporated into in silico models of membrane insertion by enforcing symmetry constraints during simulation.

In veterinary viruses, similar principles apply. For example, the fusion glycoprotein of canine distemper virus (a paramyxovirus) is a class I protein whose fusion peptide inserts as an alpha-helix. Molecular dynamics simulations of membrane-bound viral glycoproteins, as discussed in the article Molecular Dynamics Simulations of Membrane-Bound Viral Glycoproteins, can track the trajectory of the fusion peptide and its interactions with lipid headgroups and acyl chains.

Computational Workflow for Kinetics Modeling

A typical computational workflow for modeling viral envelope fusion kinetics involves multiple steps: (1) structure preparation of the fusion glycoprotein in its prefusion state, (2) membrane model generation with appropriate lipid composition, (3) docking of the protein onto the membrane, (4) enhanced sampling molecular dynamics to explore conformational transitions, and (5) free energy calculation by umbrella sampling or metadynamics. The following Mermaid diagram illustrates a decision tree for selecting a computational approach based on the research question.

graph TD
    A[Research Question], > B{Fusion mechanism?}
    B, >|Conformational changes| C[Atomistic MD with enhanced sampling]
    B, >|Free energy barrier| D[Umbrella sampling / metadynamics]
    B, >|Lipid mixing kinetics| E[Coarse-grained MD (Martini)]
    C, > F[Identify intermediate states]
    D, > G[Compute free energy profile]
    E, > H[Track stalk and pore formation]
    F, > I[Validate with cryo-EM or mutagenesis]
    G, > I
    H, > I
    I, > J[Refine model]

This workflow can be adapted for veterinary viruses such as avian influenza virus or bovine viral diarrhea virus. The choice of lipid composition in the model should reflect the host cell membrane being targeted, using data from the host species. For example, the sterol content of avian cells differs from that of mammalian cells, which affects fusion kinetics as shown by Zawada et al. [4].

Kinetics of Envelope Protein Interaction with Host Receptors

Before membrane fusion can occur, the viral envelope protein must bind to a host receptor. The kinetics of this binding event influence the overall entry rate. Nakajima et al. [8] studied the interaction of hepatitis C virus (HCV) envelope proteins with the CD81 large extracellular loop using surface plasmon resonance. They measured association and dissociation rate constants that can be integrated into kinetic models of viral entry. Although HCV is not a veterinary pathogen per se, the methodology is directly transferable to study receptor binding kinetics for veterinary viruses such as swine fever virus or feline immunodeficiency virus. The Surface Plasmon Resonance (SPR) for Viral Antigen-Antibody Kinetics article discusses these techniques in detail.

Combining receptor binding kinetics with fusion kinetics in a single computational model allows prediction of the rate-limiting step for viral entry. The statistical mechanics framework of Zhang and Dudko [3] can be extended to incorporate a receptor binding step as an additional free energy barrier.

Implications for Veterinary Virology and Antiviral Design

In silico modeling of viral envelope fusion kinetics has direct applications in veterinary medicine. For swine and poultry viruses, predicting how mutations in the fusion glycoprotein affect fusogenicity can inform risk assessments for vaccine escape or increased transmissibility. The In Silico Design of Peptide-Based Viral Entry Inhibitors Targeting Class I Fusion Proteins article describes how computational models guide the rational design of fusion inhibitory peptides. Similar strategies can be employed against class II and class III fusion proteins.

Furthermore, understanding the transition state ensemble can aid in the design of small molecules that stabilize the prefusion state or block the rearrangement. The free energy barriers calculated from simulations provide target values for inhibitor potency. The Structure-Guided Design of Broad-Spectrum Viral Fusion Inhibitors article reviews these computational approaches.

Conclusion

In silico modeling of viral envelope fusion kinetics and transition states has matured into a powerful tool for veterinary virology. By integrating atomistic simulations, free energy calculations, and experimental constraints, researchers can elucidate the conformational transitions and membrane insertion steps that drive viral entry. The papers cited here provide foundational methods and data for modeling influenza hemagglutinin [1], sterol dependence [4], statistical mechanical barriers [3], flavivirus rearrangements [2], synthetic fusion peptides [6], HIV fusion peptide structure [7], receptor binding kinetics [8], and transition state analysis of viral proteases [5]. Application of these methods to veterinary viruses will enhance our ability to predict host range, design interventions, and assess zoonotic risk.

References

[1] Pabis A, Rawle RJ, Kasson PM. Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms. Proc Natl Acad Sci U S A. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32188780/

[2] Chao LH, Klein DE, Schmidt AG, et al. Sequential conformational rearrangements in flavivirus membrane fusion. Elife. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/25479384/

[3] Zhang Y, Dudko OK. Statistical mechanics of viral entry. Phys Rev Lett. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/25615507/

[4] Zawada KE, Wrona D, Rawle RJ, et al. Influenza viral membrane fusion is sensitive to sterol concentration but surprisingly robust to sterol chemical identity. Sci Rep. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27431907/

[5] Kipp DR, Hirschi JS, Wakata A, et al. Transition states of native and drug-resistant HIV-1 protease are the same. Proc Natl Acad Sci U S A. (specific year not provided; available from Semantic Scholar). URL: https://www.semanticscholar.org/paper/ecff3966ae1e0240d999b6145645866594bffd38 *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[6] Pan J, Lai CB, Scott WR, et al. Synthetic fusion peptides of tick-borne encephalitis virus as models for membrane fusion. Biochemistry. 2010. URL: https://pubmed.ncbi.nlm.nih.gov/20000438/

[7] Qiang W, Weliky DP. HIV fusion peptide and its cross-linked oligomers: efficient syntheses, significance of the trimer in fusion activity, correlation of beta strand conformation with membrane cholesterol, and proximity to lipid headgroups. Biochemistry. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19093835/

[8] Nakajima H, Cocquerel L, Kiyokawa N, et al. Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop. Biochem Biophys Res Commun. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/15707989/